نتایج جستجو برای: repaglinide

تعداد نتایج: 366  

2005

Diabetes mellitus is associated with accelerated atherosclerosis and increased morbidity and mortality in micro-and macrovascular complications. The metabolic derangements that accompany diabetes can adversely influence platelets and vascular endothelial function, which may contribute to the pathogenesis of diabetic angiopathy. This thesis aimed to examine the effect of acute and postprandial h...

Journal: :Diabetes care 2002
Robert M Cohen Barbara A Ramlo-Halsted

The availability of diabetes drugs with new properties in the last several years has prompted excitement about potential new and unique advantages for diabetes care. That has certainly been the case with the new insulin secretagogues, repaglinide and nateglinide, which have earlier onset and shorter duration of action than the sulfonylureas. The niche that insulin secretagogues occupy brings un...

2011
Mateen Abbas Sualeha Riffat Muqeet Khan

Numerous oral antidiabetic drugs with different mechanisms of action have been developed to lower glucose and delay the occurrence of serious complications in patients with type 2diabetes [1]. For glycemic control in diabetic patients, monotherapy with an oral antidiabetic agent is not adequate to achieve satisfactory blood glucose control [2]. Thus, combination regimens which include drugs wit...

Journal: :iranian journal of basic medical sciences 0
dao li department of pharmacology, city college, wuhan university of science and technology, wuhan, china jin li department of laboratory, zhongnan hospital of wuhan university, wuhan, china hui li department of pharmacology, city college, wuhan university of science and technology, wuhan, china qiong wu department of pharmacology, city college, wuhan university of science and technology, wuhan, china qi-xiong li department of pharmacology, city college, wuhan university of science and technology, wuhan, china

objective(s): repaglinide (rg) is an antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus. it has a good safety and efficacy profile in diabetic patients with complications in renal impairment and is an appropriate treatment choice, even for individuals with more severe degrees of renal malfunctions. the aim of the present study was to examine the protective...

Journal: :Journal of Drug Delivery and Therapeutics 2019

2014
Manfred Ballmann Dominique Hubert Barouk M Assael Kai Kronfeld Marguerite Honer Reinhard W Holl

BACKGROUND Diabetes mellitus may be present in patients with cystic fibrosis starting in the second decade of life. The prevalence increases rapidly with increasing age. As life-expectancy increases in cystic fibrosis, cystic fibrosis related diabetes will be diagnosed more frequently in the future.Up to date, no data are available to answer the question if cystic fibrosis related diabetes shou...

Journal: :Brilliance 2022

The two most prevalent causes of end-stage renal disease nowadays are thought to be diabetic mellitus (DM) and hypertension (ESRD). In addition discussing the function DM in ESRD, this study reviews glucose metabolism treatment hyperglycemia these patients. Although strict glycemic control ESRD patient survival were not significantly correlated numerous big trials, it is advised that prioritise...

Journal: :Asian Journal of Pharmaceutical and Clinical Research 2018

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید